deltatrials
Completed PHASE4 NCT00166400

A Randomized Clinical Trial of Metoprolol in Participants With Mitral Regurgitation.

Beta Blockade in Mitral Regurgitation

Sponsor: AstraZeneca

Conditions Heart Valve Diseases
Interventions metoprolol succinate
Updated 6 times since 2017 Last updated: Jul 23, 2008 Started: Jul 31, 2004 Primary completion: Jul 31, 2007 Completion: Jul 31, 2007

Listed as NCT00166400, this PHASE4 trial focuses on Heart Valve Diseases and remains completed. Sponsored by AstraZeneca, it has been updated 6 times since 2004, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Jul 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AstraZeneca
  • Mayo Clinic
Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Rochester, United States